Living Related Liver Transplantation in Adults: First Year Experience at the University of Liège

• Published in: Acta chirurgica belgica 2004-04, Vol.104 (2), p.166-171
• Main Authors: Detry, O., Roover, A. De, Delwaide, J., Coimbra, C., Kaba, A., Joris, J., Damas, P., Meurisse, M., Honoré, P.
• Format: Article
• Language: English
• Subjects: Adult; Biological and medical sciences; cirrhosis; complication; Family; Gastroenterology. Liver. Pancreas. Abdomen; General aspects; Humans; Liver Diseases - surgery; liver failure; Liver transplantation; Liver Transplantation - methods; Liver. Biliary tract. Portal circulation. Exocrine pancreas; living donor; Living Donors; living transplantation; Medical sciences; Middle Aged; Other diseases. Semiology; outcome; Prospective Studies; surgery; Treatment Outcome
• ISSN: 0001-5458
• DOI: 10.1080/00015458.2004.11679529

Living related liver transplantation (LRLT) in adult recipients has been recently developed to overcome the organ donor shortage, but LRLT leaves the healthy donors at risk of serious post-operative complications, or even death. The aim of this paper is to report the prospective evaluation of the initial experience of adult LRLT at the University of Liège. From March 2002 till March 2003, in a consecutive series of 35 adult liver transplantations, five recipients (mean age: 51 years) underwent LRLT, including one retransplantation. Indications for transplantation were autoimmune hepatitis, hepatitis B virus related cirrhosis with hepatocarcinoma (two cases), hepatitis C virus related cirrhosis with hepatocarcinoma, and ischemic intrahepatic bile duct necrosis 10 years after primary liver transplantation. Mean age of the donors was 34 years (range: 21-53 years). All donation cases were intra familial at first degree. The right lobe was used as a graft in four cases and the left lobe in one case. All right lobe donors developed transient hyperbilirubinemia and hypocoagulation for 4 to 6 days. No severe complication (transfusion, bile duct fistula, reintervention, rehospital-ization) nor significant long-term sequelae were observed in the donors. In the recipients, graft function was immediate, and there was no small-for-size syndrome. One recipient developed biliary fistula treated by reoperation. One recipient died from invasive aspergillosis 11 days after the procedure. The four other recipients were alive without recurrence of the disease at follow-up. This report confirmed that LRLT may be a valuable alternative to cadaveric liver transplantation in the era of organ donor shortage. However, even if there was no severe complication for the donors in our preliminary experience, LRLT puts healthy living donors at risk of significant morbidity and even death.